Fla. Man Says Contaminated Zantac Caused Rare Cancer

MIAMI — A Florida man has sued the maker of Zantac in Florida state court, alleging it concealed the fact that its acid reflux drug Zantac (ranitidine) contained “incredibly high levels” of a probable human carcinogen.

In a complaint filed Sept. 13 in the Miami-Dade County Circuit Court, Joseph Galimidi says Sanofi Aventis knew Zantac was “laden” with n-nitrososdimethylamine (NDMA), yet failed to inform the FDA, physicians and the public of that known risk.

NDMA is classified a probable human carcinogen by the Department of Environmental Protection and was formerly used in the production of liquid rocket fuel. According …

  • Levin Citron Rodal


HarrisMartin’s Webinar Series: Surgical Stapler Litigation

January 14, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series